Brands Owned by Galderma Group AG.

Cetaphil

food and beverage brand

Cetaphil is a brand specializing in skincare products, including cleansers, moisturizers, and serums, formulated primarily for sensitive skin types. The brand positions itself as a dermatologist-recommended line focused on science-based solutions to defend against the five common signs of skin sensitivity. Its product portfolio targets a broad consumer base dealing with various skin concerns such as dryness, acne, and aging, offering specialized ranges like the Gentle Clear and Restoraderm Eczema lines.

Differin

food and beverage brand

Differin is a skincare brand owned by Galderma that specializes in over-the-counter acne treatments, cleansers, and post-acne care products. The brand is best known for its 0.1% adapalene gel, which was the first retinoid treatment for acne to be approved for over-the-counter use in the United States. Its product line is formulated to address acne, dark spots, and skin texture for consumers seeking clinical-strength dermatological solutions.

Issviva

United Kingdom

Issviva is a wellness brand that provides a range of products and educational resources specifically designed for women navigating perimenopause, menopause, and post-menopause. Its offerings include food supplements, intimate skincare, and health devices aimed at managing symptoms such as hot flushes, sleep disturbances, and mood changes. The brand positions itself as a holistic platform that combines expert-led advice with curated products to support women's physical and emotional well-being.

PILEXIL

Spain

Pilexil is a specialized brand offering a range of hair care products, including shampoos, lotions, and dietary supplements, designed to address hair loss in both men and women. Developed by Laboratorios Lacer, the brand provides solutions for various types of hair thinning, including hereditary and stress-related factors. Its products are formulated with ingredients such as vitamins, minerals, and plant extracts, and are supported by clinical efficacy studies.